Smoking, obesity, and statin therapy in the prognosis of prostate cancer.
Daniell
Harry W
HW
D015992:Body Mass Index; D018572:Disease-Free Survival; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000517:prevention & control*; D009765:Obesity / Q000150:complications* / Q000401:mortality; D011237:Predictive Value of Tests; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000150:complications / Q000175:diagnosis / Q000401:mortality* / Q000517:prevention & control* / Q000532:radiotherapy; D012907:Smoking / Q000009:adverse effects* / Q000401:mortality
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors